Effects of Endurance Exercise Training and Crataegus Extract WS® 1442 in Patients with Heart Failure with Preserved Ejection Fraction - A Randomized Controlled Trial

Impaired exercise capacity is the core symptom of heart failure with preserved ejection fraction (HFpEF). We assessed effects of exercise training and Crataegus extract WS 1442 in HFpEF and aimed to identify mechanisms of action in an exploratory trial (German Clinical Trials Register DRKS00000259)....

Full description

Saved in:
Bibliographic Details
Main Authors: Sascha Härtel (Author), Claire Kutzner (Author), Eva Westphal (Author), Matthias Limberger (Author), Martin Burkart (Author), Ulrich Ebner-Priemer (Author), Matthias Kohl-Bareis (Author), Klaus Bös (Author)
Format: Book
Published: MDPI AG, 2014-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b2b97d0a816f4b9da92f83023c60c26a
042 |a dc 
100 1 0 |a Sascha Härtel  |e author 
700 1 0 |a Claire Kutzner  |e author 
700 1 0 |a Eva Westphal  |e author 
700 1 0 |a Matthias Limberger  |e author 
700 1 0 |a Martin Burkart  |e author 
700 1 0 |a Ulrich Ebner-Priemer  |e author 
700 1 0 |a Matthias Kohl-Bareis  |e author 
700 1 0 |a Klaus Bös  |e author 
245 0 0 |a Effects of Endurance Exercise Training and Crataegus Extract WS® 1442 in Patients with Heart Failure with Preserved Ejection Fraction - A Randomized Controlled Trial 
260 |b MDPI AG,   |c 2014-09-01T00:00:00Z. 
500 |a 2075-4663 
500 |a 10.3390/sports2030059 
520 |a Impaired exercise capacity is the core symptom of heart failure with preserved ejection fraction (HFpEF). We assessed effects of exercise training and Crataegus extract WS 1442 in HFpEF and aimed to identify mechanisms of action in an exploratory trial (German Clinical Trials Register DRKS00000259). 140 sedentary HFpEF NYHA II patients on standard treatment received eight weeks of aerobic endurance training and half were randomized to WS 1442 900 mg/day. Symptoms, 2 km walking time (T2km), parameters of exercise tolerance, cardiac and vascular function, muscular efficiency and skeletal muscular haemoglobin oxygen saturation (SO2) measured during a treadmill protocol were captured at baseline and after eight weeks. Adverse events were recorded during the trial. Mechanisms of action were explored by correlation and path analyses of changes. Symptoms and exercise capacity improved with training, but correlations between improvements were low and path models were rejected. SO2 increased, decreased or undulated with increasing exercise intensity in individual patients and was not altered by training. WS 1442 improved T2km (-12.7% vs. -8.4%, p = 0.019), tended to improve symptoms and to pronounce SO2-decrease with increasing exercise, an indicator of oxygen utilisation. Endurance training and WS 1442 were safe and well tolerated in combination with standard drug treatment. 
546 |a EN 
690 |a heart failure 
690 |a HFpEF 
690 |a training 
690 |a Crataegus 
690 |a WS 1442 
690 |a NIRS 
690 |a Sports 
690 |a GV557-1198.995 
655 7 |a article  |2 local 
786 0 |n Sports, Vol 2, Iss 3, Pp 59-75 (2014) 
787 0 |n http://www.mdpi.com/2075-4663/2/3/59 
787 0 |n https://doaj.org/toc/2075-4663 
856 4 1 |u https://doaj.org/article/b2b97d0a816f4b9da92f83023c60c26a  |z Connect to this object online.